Looking for volunteers
Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy
NCT06839716 · Gangnam Severance Hospital · Updated 25 Feb 2025
- What is being tested
- Arm I (Ropivacaine-Poloxamer 407 hydrogel group); Arm II (TAP block group)
- For
- Gastric Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years and older. About 134 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 1 Feb 2025, ends 31 March 2026. Registered 21 Feb 2025.
- Results
- None posted yet.
In the researchers' words
This study aims to determine whether Ropivacaine-Poloxamer 407 hydrogel provides non-inferior pain control compared to TAP block for patients undergoing minimally invasive gastrectomy. The results will guide postoperative pain management practices and enhance recovery protocols for gastric cancer surgery.
Sites
- Gangnam Severance HospitalSeoul, South Korea